224
Participants
Start Date
July 31, 2007
Primary Completion Date
November 30, 2007
Study Completion Date
November 30, 2007
Lapaquistat acetate
Lapaquistat acetate 100 mg, tablets, orally, once daily in the morning and Lapaquistat acetate placebo-matching tablets, orally, once daily in the evening for up to six weeks.
Lapaquistat acetate
Lapaquistat acetate placebo-matching tablets, orally, once daily in the morning and Lapaquistat acetate 100 mg, tablets, orally, once daily in the evening for up to six weeks.
Lapaquistat acetate
Lapaquistat acetate 50 mg, tablets, orally, once daily in the morning and Lapaquistat acetate 50 mg, tablets, orally, once daily in the evening for up to six weeks.
Placebo
Lapaquistat acetate placebo-matching tablets, orally, once daily in the morning and Lapaquistat acetate placebo-matching tablets, orally, once daily in the evening for up to six weeks.
Long Beach
Sacramento
San Diego
Hollywood
Jacksonville
New Port Richey
Chicago
Wichita
Louisville
Margate City
Charlotte
Raleigh
Statesville
Wilmington
Winston-Salem
Medford
Perkasie
Sellerville
Bristol
Norfolk
Richmond
Madison
Lead Sponsor
Takeda
INDUSTRY